Zeynep Toker Dincer

Zeynep Toker Dincer

Auto-generated profile, based on publicly available information

Zeynep Toker Dincer

Division of Rheumatology, Department of Internal Medicine, Cerrahpaşa Medical Faculty, İstanbul University-Cerrahpaşa, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


15 August 2024 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
ZDZeynep Toker Dincer
Zeynep Toker Dincer
MDMevlut Tamer Dincer
Mevlut Tamer Dincer
GSGozde Serife Sen
Gozde Serife Sen
SUSerdal Ugurlu
Serdal Ugurlu
NSNurhan Seyahi
Nurhan Seyahi
ESEmire Seyahi
Emire Seyahi

9 July 2024 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
ZDZeynep Toker Dincer
Zeynep Toker Dincer
MDMevlut Tamer Dincer
Mevlut Tamer Dincer
SYSerkan Yalin
Serkan Yalin
STSinan Trabulus
Sinan Trabulus
NSNurhan Seyahi
Nurhan Seyahi
MAMehmet Riza Altiparmak
Mehmet Riza Altiparmak

12 August 2025 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
ZDZeynep Toker Dincer
Zeynep Toker Dincer
MAMuhammed Bahaddin Ates
Muhammed Bahaddin Ates
ADAyten Dag
Ayten Dag
ITIlayda Turkoglu
Ilayda Turkoglu
SUSerdal Ugurlu
Serdal Ugurlu

25 April 2026 in Internal Medicine Journal
Verified
Journal Article
Open access
PDF file
ZDZeynep Toker Dincer
Zeynep Toker Dincer
DRDamla Raimoglou
Damla Raimoglou
EYErkin Yilmaz
Erkin Yilmaz
ADAyten Dag
Ayten Dag
MMMelike Melikoglu
Melike Melikoglu
SUSerdal Ugurlu
Serdal Ugurlu
Aim: Idiopathic recurrent pericarditis (IRP) is considered an autoinflammatory disease, and interleukin 1 inhibitors, such as anakinra, are used to treat resistant cases. Constrictive pericarditis, a feared complication, continues to be a critical concern. In the biologic era, evidence on long‐term transthoracic echocardiographic (TTE) findings following anakinra treatment remains limited. Methods: We conducted a cross‐sectional study that included 18 patients with IRP treated with anakinra who had been attack‐free for at least 3 months. TTE was performed on all patients and 21 healthy controls, and findings were compared between the groups. Results: Pericardial thickness was significantly increased in patients compared with controls (3.1 mm (interquartile range (IQR): 3.0–3.4) vs 2.1 mm (IQR: 1.9–2.4), P < 0.001). None of the patients exhibited echocardiographic signs of constrictive pericarditis. Mild pericardial effusion was present in nine patients (50%) despite being attack‐free. Pericardial hyperechogenicity was observed in 61.1% of the patient group and 23.8% of the control group ( P = 0.018). In the subgroup analysis of patients receiving ongoing anakinra treatment and those who had discontinued, there were no significant differences in pericardial thickness ( P = 0.573), pericardial effusion ( P = 0.637) or pericardial hyperechogenicity ( P = 0.066). Conclusion: In conclusion, despite the refractory course of the disease, no cases of constrictive pericarditis were identified. TTE evaluation revealed increased pericardial thickness in patients who received anakinra compared with healthy controls, despite being attack‐free. Further studies are needed to clarify whether the presence of pericardial thickening or ongoing pericardial effusion should influence treatment planning.